PPC CPP. Thank You Merci bien CSHP SCPH EXCELLENCE IN PHARMACY PRACTICE EXCELLENCE EN PRATIQUE PHARMACEUTIQUE FINAL PROGRAM 46PROGRAMME FINAL

Transcription

1 PPC CPP ANNUAL PROFESSIONAL PRACTICE CONFERENCE January 3 - February 4, 05 CONFÉRENCE ANNUELLE SUR LA PRATIQUE PROFESSIONNELLE 3 janvier - 4 février 05 FINAL PROGRAM 46PROGRAMME FINAL The Sheraton Centre Toronto Hotel 3 Queen Street West Commemorative Issue Numéro commémoratif CSHP SCPH EXCELLENCE IN PHARMACY PRACTICE EXCELLENCE EN PRATIQUE PHARMACEUTIQUE Thank You Merci bien FOR PAVING THE WAY D OUVRIR LA VOIE

2 Along the bottom of every page of this program is a list of the 00 pharmacy departments who committed to CSHP 05 by: Making CSHP 05 part of their pharmacy s strategic plan Encouraging and supporting their pharmacists to improve the effective, evidence-based and safe use of medications through CSHP 05 Sharing success stories related to the implementation of CSHP 05 objectives Promoting the pharmacist in quality patient care GOALS Increase the extent to which pharmacists help individual hospital inpatients achieve the best use of medications Increase the extent to which pharmacists help individual non-hospitalized patients achieve the best use of medications Increase the extent to which hospital and 3 related healthcare setting pharmacists actively apply evidence-based methods to the improvement of medication therapy Increase the extent to which pharmacy 4 departments in hospitals and related healthcare settings have a significant role in improving the safety of medication use Increase the extent to which hospitals and 5 related healthcare settings apply technology effectively to improve the safety of medication use Increase the extent to which pharmacy 6 departments in hospitals and related healthcare settings engage in public health initiatives on behalf of their communities BUTS Accroître le degré d intervention des pharmaciens auprès de chaque patient hospitalisé afin d assurer l utilisation optimale des médicaments Accroître le degré d intervention des pharmaciens auprès de la clientèle non hospitalisée afin d assurer une utilisation optimale des médicaments Étendre l application du principe des décisions 3 fondées sur les preuves à la pratique clinique quotidienne des pharmaciens des établissements de santé dans le but d améliorer la pharmacothérapie Accroître le rôle joué par les départements 4 de pharmacie des établissements de santé dans l amélioration de l utilisation sécuritaire des médicaments Étendre l application efficace des technologies 5 dans les départements de pharmacie des établissements de santé pour améliorer l utilisation sécuritaire des médicaments 6 Accroître le degré d intervention des départements de pharmacie des établissements de santé dans la mise en oeuvre d initiatives de santé publique ALBERTA: AHS Clinical, Education, Operations Mgrs AHS Central, Calgary & Edmonton

3 of the objectives now align with Accreditation Canada s 03 medication management standards We ve seen the number of pharmacy residency program positions increase by: CSHP SCPH EXCELLENCE IN PHARMACY PRACTICE EXCELLENCE EN PRATIQUE PHARMACEUTIQUE from 7 in 007 to over 00 in Thank you to our sponsors: 50 % of the targets were reached or within reach! Branches caring for life FAMILY OF CONSUMER COMPANIES The final CSHP 05 progress update as part of the Hospital Pharmacy in Canada 03/4 Report will be released in the spring of 05 and will be available at Zones Alberta Children s Hospital Alberta Hospital Bentley Care Centre Centennial 3

4 Dear Colleague, On behalf of the Officers, Board and staff of the Canadian Society of Hospital Pharmacists (CSHP), it is our pleasure to welcome you to CSHP s 46th Annual Professional Practice Conference. Over the last 0 months, CSHP s Educational Services Committee has worked hard to assemble an impressive faculty of pharmacy specialists and develop a program of exceptional educational value with topics covering a wide range of specialties, management issues and pharmacy practice-related challenges. This conference is designed to maximize your opportunities for professional development, networking and socializing with practitioners from across the country. It is our hope that you are able to take full advantage of the 05 offerings and enjoy yourself in the process. This year marks the culmination of the CSHP 05 initiative Targeting Excellence in Pharmacy Practice. This conference will celebrate the work done to date and will examine if this initiative has made a difference to pharmacy practice in Canada. At any time throughout the conference, the Officers and staff of CSHP are available to you. Please let us know if we can answer any of your questions, address any of your concerns or be of assistance in any way. We look forward to welcoming each of you to another spectacular conference. Thank you for your ongoing support of CSHP! Bruce Millin BSc(Pharm), ACPR CSHP President Myrella Roy BScPhm, PharmD, FCCP Executive Director 4 Centre for Mental Health and Brain Injury Consort Hospital and Care Centre Drayton

5 Chères (Chers) collègues, Au nom de la Direction, du Conseil et du personnel de la Société canadienne des pharmaciens d hôpitaux (SCPH), nous avons le plaisir de vous souhaiter la bienvenue à la 46 e Conférence annuelle sur la pratique professionnelle de la SCPH. Au cours des dix derniers mois, le comité des services éducatifs de la SCPH s est affairé à rassembler un groupe impressionnant de conférenciers spécialisés en pharmacie et à vous préparer un programme d une valeur éducative exceptionnelle avec des sujets touchant un large éventail de spécialités, de questions relatives à la gestion et de défis posés à la pratique pharmaceutique. Ce congrès est destiné à maximiser les possibilités de perfectionnement professionnel, de réseautage et de rencontre avec d autres praticiens de toutes les régions du pays. Nous espérons que vous pourrez tirer pleinement profit de ce que nous vous offrons en 05 tout en vous divertissant. Cette année marque le point culminant du projet SCPH 05 Point de mire sur l excellence en pratique pharmaceutique. Ce congrès célèbrera le travail accompli à ce jour et permettra de voir si ce projet aura réussi à changer la pratique de la pharmacie au Canada. Nous vous rappelons qu au cours du congrès, la Direction et le personnel de la SCPH seront à votre entière disposition. Nous ferons tout en notre pouvoir pour répondre à vos questions, discuter des sujets qui vous préoccupent et vous aider au besoin de quelques manières que ce soit. Nous sommes impatients de vous accueillir à cet autre congrès exceptionnel et vous remercions de votre appui soutenu à la SCPH. Bruce Millin Myrella Roy B. Sc. (Pharm.), ACPR B. Sc. Phm., Pharm. D., FCCP Président de la SCPH Directrice générale Valley Hospital and Care Centre Drumheller Health Centre Edmonton General Continuing 5

6 Table of Contents CSHP Board and Staff Table des matières Conseil SCPH et personnel Executive Committee Bureau de direction 6 Branch, A.P.E.S. and Student Delegates Délégués des sections et de l A.P.E.S., et déléguée étudiante 7 CSHP Staff Personnel de la SCPH 7 With Thanks Remerciements CSHP Sponsors 04 Commanditaires de la SCPH en 04 9 CSHP Industry Corporate Supporters Entreprises partisanes du secteur de l industrie 0 CSHP Hospital Corporate Supporters Entreprises partisanes du secteur hospitalier 0 CSHP 05 Initiative Acknowledgements Remerciements à l égard du projet SCPH Conference Information Information sur la conférence Upcoming Events Événements à venir Satellite Symposiums Symposiums satellites CSHP Educational Services Committee Comité des services éducatifs Program Programme Program of Events Programme des événements 3 Speakers Abstracts Résumés des conférenciers 0 SES 05 Call for Abstracts Demande de résumés pour les SÉÉ Oral Presentations Présentations orales 43 Poster Abstracts Résumés des affiches 44 Poster Abstract Reviewers Réviseurs des présentations par affiches 65 Faculty Conférenciers 66 Exhibitor List Liste des exposants 68 Executive Committee Bureau de direction President Président Bruce Millin Fraser Health Authority Langley, BC President Elect Président désigné Glen Pearson Mazankowski Alberta Heart Institute Edmonton, AB Past President Présidente sortante Patricia Macgregor The Hospital for Sick Children Treasurer Trésorière Deborah Emery Thunder Bay Regional Health Sciences Centre Thunder Bay, ON Executive Director Directrice générale Myrella Roy Canadian Society of Hospital Pharmacists Société canadienne des pharmaciens d hôpitaux Ottawa, ON 6 Care Centre Foothills Medical Centre Fort Saskatchewan Health Centre Grey Nuns

7 Branch, A.P.E.S. and Student Delegates Délégués des sections et de l A.P.E.S., et déléguée étudiante British Columbia Colombie-Britannique Shirin Abadi BC Cancer Agency Vancouver, BC Alberta Tania Mysak University of Alberta Hospital Edmonton, AB Saskatchewan Zack Dumont Regina Qu Appelle Health Region Regina, SK Manitoba Pat Trozzo CancerCare Manitoba Winnipeg, MB CSHP Staff Personnel de la SCPH Ontario Senior/Principal Mario Bédard The Ottawa Hospital Ottawa, ON Ontario Junior/Débutante Christina Adams North West Telepharmacy Solutions Pembroke, ON A.P.E.S / Québec Diem Vo Hôpital Pierre-Boucher Longueuil, QC New Brunswick Nouveau-Brunswick Pamela Yafai Saint John Regional Hospital Saint John, NB Nova Scotia Nouvelle-Écosse Kim Abbass Cape Breton Regional Hospital Sydney, NS Prince Edward Island Île-du-Prince-Édouard Amy Carpenter Kings County Memorial Hospital Montague, PE Newfoundland and Labrador Terre-Neuve-et-Labrador Justin Peddle Memorial University St. John s, NL Student Étudiante Jaskiran Otal University of Waterloo Waterloo, ON Executive Director Directrice générale Myrella Roy Operations Manager (on leave) Gérante des opérations (en congé) Laurie Frid Interim Operations Manager Gérante des operations par intérim Desarae Davidson Coordinator, Professional & Membership Affairs Coordonnatrice, Affaires professionnelles et service aux membres Cathy Lyder Executive Assistant Adjointe de direction Rosemary Pantalone Interim Conference & PSN Administrator Agente par intérim des congrès et des RSP Susan Maslin Membership & Awards Administrator Agente du service aux membres et des prix Robyn Rockwell CPRB Administrator Agente du CCRP Gloria Day Finance Administrator Agente des finances Anna Dudek Publications Administrator Agente des publications Suzanne Purkis Web Administrator Agente du Web Olga Chrzanowska Ontario Branch & Advocacy Executive Assistant Adjointe de direction de la section de l Ontario et de la valorisation Anne Stacey Office Administrator (CSHP 05 & Fellows [FCSHP] Recognition Committee) Agente de bureau (SCPH 05 et Comité de reconnaissance des associés [FCSHP]) Pamela Saunders CSHP 05 Project Coordinator Coordonnatrice du projet SCPH 05 Carolyn Bornstein CSHP Foundation Administrator Agente de la Fondation de la SCPH Janet Lett Community Hospital Hanna Health Centre Innisfail Health Centre Leduc Community 7

8 sponsorship The Canadian Society of Hospital Pharmacists (CSHP) is the national voluntary organization of pharmacists committed to patient care through the advancement of safe, effective medication use in hospitals and other collaborative health care settings. Founded in 947, CSHP is a member-driven association which operates at several levels: national, provincial branches, local chapters, committees, and task forces. CSHP is thriving and now supports 3400 adherent (members and supporters) through: Advocacy Education: Professional Practice Conference, Banff Seminar, Summer Educational Sessions, and numerous branch and chapter educational sessions Information Sharing: Publication of the Canadian Journal of Hospital Pharmacy, Discussion Forums through the Pharmacy Specialty Networks Development of Guidelines for Best Practices Facilitation of Research: Grants through the Research and Education Foundation Recognition of Excellence: Awards Program and Fellows Program CSHP 05: A quality program proposing 36 objectives to achieve a vision of pharmacy practice excellence in the year 05 together we make a difference 8 Hospital Mazankowski Alberta Heart Institute Misericordia Community Hospital Olds

9 CSHP Sponsors 04 The following list reflects all sponsorship received from January to December 3, 04. Commanditaires de la SCPH en 04 La liste suivante reflète toutes les commandites reçues du premier janvier au 3 décembre 04. Diamond Sponsor Commanditaires diamant $80,000 or greater $ et plus caring for life Platinum Sponsor Commanditaires platine $60,000 - $79,999 Gold Sponsor Commanditaires or $40,000 - $59,999 AstraZeneca Canada Ltd. Sandoz Canada Inc. Silver Sponsor Commanditaires argent $0,000 - $39,999 Apotex Inc. Eli Lilly Canada Inc. Hospira Healthcare Corporation Mylan Canada Sanofi Canada Teva Canada Limited Bronze Sponsor Commanditaires bronze $0,000 - $9,999 Alveda Pharmaceuticals Inc. Astellas Pharma Canada Bayer Inc. Canadian Patient Safety Institute LEO Pharma Inc. Omega Laboratories Limited Pharmascience Inc. SteriMax Inc. Sunovion Pharmaceuticals Inc. Donor Sponsor Commanditaires donateurs $000 - $9,999 Abbott Laboratories Inc. AbbVie Corporation Accord Healthcare Inc. AirClean Systems Canada AmerisourceBergen Amgen Canada Inc. Association of Allied Health Professionals AutoMed Technologies Inc. B.Braun Medical Inc. Baxter Corporation (Canada) BCE Pharma Inc. BD Medical BioSyent Pharma Inc. BMS Pfizer Alliance Boehringer-Ingelheim Canada Ltd. Calea Canadian Agency for Drugs and Technologies in Health Canadian Forces Canadian Institute for Health Information Canadian Pharmaceutical Distribution Network College of Pharmacists of British Columbia Cubist Pharmaceuticals Galenova Global Medical Products Healthmark Services Ltd. HealthPRO Hoffman La Roche Limited Janssen-Ortho Johnson & Johnson Kit Check Lexicomp Inc. Lundbeck Canada Inc. McKesson Canada Corporation MDA Inc. Medbuy Medisca Corporation Merck Canada Inc. Memorial University School of Pharmacy Newfoundland and Labrador Centre for Health Information North West Telepharmacy Solutions Novartis Pharma Canada Novo Nordisk Canada Inc. Omnicell Ontario College of Pharmacists Otsuka Pharmaceutical Inc. PCCA Canada Pendopharm, A Divison of Pharmascience Inc. Pharmacists Association of Newfoundland and Labrador QleanAir Scandinavia RxFiles Academic Detailing Program Scotiabank Servier Canada Inc. Sphynx Medical Inc. Sunovion Pharmaceuticals Inc. Swisslog Healthcare Solutions Takeda Truven Health Analytics University of Florida Working Professional Doctor of Pharmacy Program University of Toronto Valeant Canada Wolters Kluwer Clinical Drug Information Hospital and Care Centre Peter Lougheed Centre Ponoka Hospital and Care Centre 9

10 04-05 CSHP Industry Corporate Supporters This list recognizes our Industry Corporate Supporters for the year July, 04 - June 30, 05 (At time of printing) Entreprises partisanes du secteur de l industrie La liste suivante reconnaît nos entreprises partisanes du secteur de l industrie au cours de l année d adhésion du premier juillet 04 au 30 juin 05 (au moment de l impression) Accord Healthcare Inc. Alveda Pharmaceuticals Inc. Baxter Corporation (Canada) Bayer Inc. BCE Pharma Inc. Eli Lilly Canada Inc CSHP Hospital Corporate Supporters This list recognizes our Hospital Corporate Supporters for the year July, 04 - June 30, 05 (At time of printing) Entreprises partisanes du secteur hospitalier La liste suivante reconnaît nos entreprises partisanes du secteur hospitalier au cours de l année d adhésion du premier juillet 04 au 30 juin 05 (au moment de l impression) Horizon Health Network London Health Sciences Centre Lower Mainland Pharmacy Services Northern Health Authority North West Telepharmacy Solutions University Health Network Fresenius Kabi Canada Ltd. Galenova Inc. Healthmark Services Ltd. Hospira Healthcare Corporation Johnson & Johnson Inc. MDA Inc. Mylan Canada Omega Laboratories Ltd. Pendopharm, a Division of Pharmascience Inc. Pharmascience Inc. Sandoz Canada Inc. Servier Canada Inc. SteriMax Inc. TEVA Canada Limited Valeant Canada 0 Redwater Health Centre Rimbey Hospital and Care Centre Rocky Mountain House Health

11 Upcoming Events Événements à venir Professional Practice Conference (PPC): January 30-February 3, 06 Sheraton Centre Toronto Hotel February 4-8, 07 InterContinental Toronto Centre Summer Educational Sessions (SES): Join us as we retire the SES program in 05. Please note the date as it is a week later than usual. August 5-8, 05 Westin Hotel Ottawa, Ontario Attendance at CSHP conferences, PPC and SES, are approximately 500 and 50 respectively, excluding exhibitors. Please note we offer an exhibit program at both events. For further information, please contact Susan Maslin, Interim Conference & PSN Administrator. Tel.: (63) , ext. 9 Fax: (63) smaslin@cshp.ca Satellite Symposiums Symposiums satellites CSHP would like to thank the following sponsors of Satellite Symposiums for their participation in conjunction with the PPC 05. Sunday, February Satellite Symposium SPONSORSHIP OPPORTUNITY :00-3:30 Bayer Inc. Monday, February 7:30-9:30 The France Foundation McKesson Canada Corporation Tuesday, February 3 7:30-9:30 Canadian Cardiovascular Pharmacists Network Hospira Healthcare Corporation See the program section for more details. 68th Summer Educational Sessions The Westin Ottawa Ottawa, ON Aug 5-8, 05 Breakfast and Luncheon Opportunities For more information please contact Susan Maslin Interim Conference and PSN Administrator (63) , ext 9 or smaslin@cshp.ca Centre Rockyview General Hospital Royal Alexandra Hospital St. Mary s Hospital

12 The Educational Services Committee Le comité des services éducatifs EP C.C.C.E.P Canadian Council on Continuing Education in Pharmacy Chairperson Président Clarence Chant, PharmD, FCSHP, FCCP St. Michael s Hospital Staff Liaison Employée de liaison Susan Maslin Members Membres Margaret Ackman, PharmD, FCSHP Alberta Health Services Edmonton, AB Bernadette Almeida, RPh, BScPhm, ACPR Trillium Health Partners Jessica Beach, BScPharm Interior Health Practice Resident Kelowna, BC Roxane Carr, PharmD, BCPS, FCSHP BC Children s and Women s Health Centre Vancouver, BC Lorie Carter, BSc(Pharm) Eastern Health Marystown, NL Elaine Chong, PharmD, BCPS BC Ministry of Health Services New Westminster, BC Judy Chong, BScPhm Ontario College of Pharmacists Leah Edmonds, BScPhm QEII Health Sciences Centre Halifax, NS Alfred Gin, PharmD, FCSHP Health Sciences Centre Winnipeg, MB Derek Jorgenson, BSP, PharmD, FCSHP University of Saskatchewan Saskatoon, SK Sharan Lail, BScPhm, ACPR St. Michael s Hospital Kat Timberlake, PharmD The Hospital for Sick Children Erica Wang, BScPhm, PharmD Kelowna General Hospital Kelowna, BC The Educational Services Committee (ESC) of CSHP has been working for approximately 0 months on the content and format of PPC 05. The committee also plans the Summer Educational Sessions, in conjunction with the local host task force and the national office. The ESC is comprised of a core committee of 5 CSHP members as well as corresponding members from the CSHP branches. Goal and Objectives for the 05 PPC Program Goal: To provide registrants with quality educational sessions. Objectives: To provide educational sessions which inform, educate and motivate clinical practitioners and managers. To provide leadership in hospital pharmacy practice by presenting sessions on innovative pharmacists roles, pharmacy practice and pharmacy programs. To promote life-long learning skills through active participation in problembased workshops. To provide registrants with networking and sharing opportunities through the exhibits program and poster sessions. To promote excellence in pharmacy practice research through oral and poster presentations of original work and award-winning projects. To provide an opportunity for Pharmacy Specialty Networks to meet and share their expertise with others. Le comité des services éducatifs travaille depuis près de 0 mois à l élaboration du contenu et de la forme de la CPP 05. Le comité prépare aussi les Séances éducatives d été de la SCPH en collaboration avec le groupe de travail hôte local et le personnel de la SCPH. Le comité comprend 5 membres principaux et membres correspondants des sections de la SCPH. But et objectifs du programme de la CPP 05 But : Présenter des conférences éducatives de qualité aux participants. Objectifs : Présenter aux personnes inscrites des conférences éducatives susceptibles d informer, d instruire et de motiver les cliniciens et les gestionnaires. Orienter la pratique de la pharmacie hospitalière en présentant des conférences sur les nouveautés touchant le rôle du pharmacien, la pratique de la pharmacie et les programmes de pharmacie. Développer des habiletés pour un apprentissage continu par une participation active à des ateliers de formation axés sur la résolution de problèmes. Donner aux participants des occasions de réseautage et d échanges grâce au salon des exposants, aux séances d affichage et aux discussions interactives structurées. Promouvoir l excellence dans la recherche en pratique pharmaceutique par des présentations orales et des séances d affichage sur des travaux originaux et des projets primés. Donner l occasion aux réseaux de spécialistes en pharmacie de se réunir et de partager leur savoir-faire. Stettler Hospital and Care Centre Stollery Children s Hospital Sturgeon Community

13 Program Programme Saturday, January 3 Samedi 3 janvier :00-7:00 Registration Inscription CONCOURSE COAT CHECK :00-4:00 Ontario Hospital Pharmacy Residency Program Information Session (Cycle 06-07) BIRCHWOOD BALLROOM 5:00-7:00 CPRB Residency Networking Reception Réception de réseautage relative à la résidence du CCRP CIVIC BALLROOM 7:00-9:00 Career Opportunities Evening Soirée de perspectives d emploi CONCOURSE LEVEL 9:00-:00 CSHP 05 Celebration and Opening Reception Everyone welcome Célébration du projet SCPH 05 et réception d ouverture Bienvenue a tous DOMINION BALLROOM Sunday, February Dimanche er février Sponsored by Pfizer Canada Inc. 08:30-7:00 Registration Inscription CONCOURSE COAT CHECK Séance animée de présentations par affiches Discussions sur des projets de recherche originale, des projets primés et des projets dans le domaine de la pratique pharmaceutique CITY HALL AND CHURCHILL :00-3:30 Satellite Symposium Luncheon included Symposium satellite Dîner inclus DOMINION BALLROOM New Oral Anticoagulants: Real Life Application Bill Semchuk, MSc, PharmD, FCSHP Regina Qu Appelle Health Region Regina, SK Benjamin Bell, MD FRCPC North York General Hospital North York, ON Anil Chopra, MD, FRCPC University Health Network Sponsored by Bayer Inc. 3:45 4:30 Concurrent Sessions Séances concomitantes. Clinical Renal Drug Dosing: Is Cockcroft-Gault Dead? BIRCHWOOD BALLROOM Marisa Battistella, BScPhm, PharmD University of Toronto 09:00-09:5 Opening Remarks Remarques préliminaires DOMINION BALLROOM 09:5-0:5 CPSI Patient Safety Lecture Conférence de l ICSP sur la sécurité des patients DOMINION BALLROOM After the Error: Failure to Success Dr. Brian Goldman, MD, MCFP(EM), FACEP Mount Sinai Hospital Sponsored by the Canadian Patient Safety Institute 0:30-:00 Facilitated Poster Session Discussions of original research, award winning projects and pharmacy practice projects Hospital Sundre Hospital and Care Centre Three Hills Health Centre University of 3

14 . Drug-Induced Sexual Dysfunction CHESTNUT Luis Viana, BScPhm, MEd, PharmD, ACPR, CGP University of Waterloo Waterloo, ON 3. Knowledge Translation Research Primer for Pharmacists: A Practical Approach MAPLE Monika Kastner, PhD St. Michael s Hospital 4. The Hospital Pharmacist: Back to the Future PINE Bill Wilson, RPh, BSP, FCSHP Mount Sinai Hospital 4:45-6:45 Workshops & PSN Sessions Ateliers et séances des RSP. Geriatrics PSN RSP en gériatrie CHESTNUT Guidance on Guidelines: Applying the New Hypertension and Diabetes Guidelines to the Oldest Old Cheryl Sadowski, BSc(Pharm), PharmD, FCSHP University of Alberta Edmonton, AB Medication-Related Emergency Room Admissions in the Elderly Saurabh Patel, BScPharm Orillia Soldiers Memorial Hospital Orillia, ON. Internal Medicine PSN RSP en médecine interne BIRCHWOOD BALLROOM Overview of Inhalers for Chronic Obstructive Pulmonary Disease: Hospital Formulary Considerations Lawrence Jackson, BScPhm Sunnybrook Health Sciences Centre Rosa Maria Tanzini, BScPharm St. Michael s Hospital The ASP of ASP iration Pneumonia: A Stewardly Approach to the Diagnosis and Treatment of Aspiration Pneumonia Kevin Duplisea, BScPharm, PharmD, ACPR University Health Network 3. Workshop Atelier PINE Creating a Culture of Recognition Sean Spina, BSc(Pharm), ACPR, PharmD Sherry Lalli, BSc(Pharm), ACPR Vancouver Island Health Authority Victoria, BC 4. Workshop Atelier MAPLE From Rags to Riches: How to Turn Residency Research Projects into Publications Sheri Koshman, BScPharm, PharmD, ACPR University of Alberta Edmonton, AB Winnie Seto, BScPhm, PharmD, MSc, ACPR, RPh The Hospital for Sick Children 7:00-9:00 Awards Ceremony Everyone welcome Cérémonie de remise des prix Bienvenue à tous DOMINION BALLROOM Monday, February Lundi février Sponsored by Hospira Healthcare Corporation 07:30-7:00 Registration Inscription CONCOURSE COAT CHECK 08:5-08:30 Announcements Annonces DOMINION BALLROOM 08:30-09:30 Plenary Session Séance plénière Has CSHP 05 Really Made a Difference? Did We Hit the Target? DOMINION BALLROOM Neil MacKinnon, BSc(Pharm), MSc(Pharm), PhD University of Cincinnati Cincinnati, OH 4 Alberta Hospital Villa Caritas Westview Health Centre BRITISH COLUMBIA: Burnaby

15 Olavo Fernandes, BScPhm, ACPR, PharmD, FCSHP University Health Network Moderator: Carolyn Bornstein, BScPhm, ACPR, FCSHP, CGP Southlake Regional Health Centre Newmarket, ON 09:45-0:5 Break, Exhibits Pause, Kiosques SHERATON/OSGOODE HALLS 0:0-:30 Panel Discussion Panel DOMINION BALLROOM PharmD.0: What Does the New Post- Professional PharmD Mean for Me? Jill Hall, BScPharm, ACPR, PharmD University of Alberta Edmonton, AB Neil MacKinnon, BSc(Pharm), MSc(Pharm), PhD University of Cincinnati Cincinnati, OH Tom Brown, PharmD Women s College Hospital Moderator: Margaret Ackman, BSc(Pharm), PharmD, FCSHP Alberta Health Services Edmonton, AB :40-:5 Concurrent Sessions Séances concomitantes. Clinical Trials in Internal Medicine That Will Change Your Practice DOMINION BALLROOM Sharan Lail, BScPhm, ACPR St. Michael s Hospital. Oral Abstract Session Intriguing Papers from Original Research, Award Winners and Research and Education Grants a. Assessing the Impact of an Expanded Scope of Practice for Pharmacists at a Community Hospital Soomi Hwang, BSc(Pharm), RPh Surrey Memorial Hospital Surrey, BC b. Quality Improvement of Non-Sterile Compounding in Winnipeg Regional Health Authority Pharmacies Donna Woloschuk, PharmD, MEd, FCSHP Winnipeg Regional Health Authority Winnipeg, MB c. Optimized Dosing of Cefazolin in Patients on Nocturnal Home Hemodialysis Marisa Battistella, BScPhm, PharmD University Health Network 3. The Management of Traumatic Brain Injury BIRCHWOOD BALLROOM Paola Saccucci, BSc(Hons), RPh, PharmD St. Michael s Hospital 4. Business Plan Preparation for Pharmacists: How to Get Your Ideas Noticed CHESTNUT Amanda Goodwin, BSP, RPh, MBA University of Toronto :30-3:50 Lunch, Exhibits, Posters Dîner, Kiosques, Affiches SHERATON/OSGOODE HALLS 4:00-5:00 Changes to Interim Federal Health, the Effects on Refugees and the Health Care Community Response DOMINION BALLRO OM Séance d exposés oraux Communications fascinantes choisies parmi les travaux de recherche originale et les projets des récipiendaires de prix, de bourses de recherche et de perfectionnement MAPLE Hospital Children s & Women s Hospital Delta Hospital Eagle Ridge Hospital GF 5

16 Doug Gruner, MD, CCFP, FCFP University of Ottawa Ottawa, ON 5:0-7:0 Workshops & PSN Sessions Ateliers et séances des RSP. Global Health PSN RSP en santé mondiale CHESTNUT Development of International Advanced Pharmacy Practice Experiences for Student Pharmacists: The Purdue University Experience in Global Health in Kenya and Nuclear Pharmacy in England James E. Tisdale, PharmD, BCPS, FCCP, FAPhA, FAHA Purdue University Indianapolis, ID Pain Management in Developing Countries Doret Cheng, BScPharm, PharmD University of Toronto. Surgery PSN RSP en chirurgie BIRCHWOOD BALLROOM Implementation of Enhanced Recovery after Surgery Programs Robin McLeod, MD, FRCS, FACS Cancer Care Ontario New Warnings about Use of Hydroxyethyl Starch (HES) Solutions Eric Romeril, BSc, BScPharm, ACPR Hamilton Health Services Burlington, ON 3. Workshop Atelier MAPLE From Rags to Riches: How to Turn Residency Research Projects into Publications (Encore) Sheri Koshman, BScPharm, PharmD, ACPR University of Alberta Edmonton, AB Winnie Seto, BSc(Pharm), PharmD, MSc, ACPR, RPh The Hospital for Sick Children 4. Workshop Atelier PINE Creating a Culture of Recognition (Encore) Sean Spina, BSc(Pharm), ACPR, PharmD Sherry Lalli, BSc(Pharm), ACPR Vancouver Island Health Authority Victoria, BC 7:30-9:30 Satellite Symposiums Dinner included Symposiums satellites Souper inclus. The Changing Future of Biological Therapy: Clinical Implications of Biosimilars DOMINION BALLROOM Dan Martinusen, BSc(Pharm), ACPR, PharmD (Chair) Vancouver Island Health Authority, Victoria, BC Flay Charbonneau, BSc(Pharm) Sunnybrook Health Sciences Centre George Dranitsaris, BPharm, MS, PhD, FCSHP Augmentium Pharma Consulting Guelph, ON Hosted by The France Foundation. New Provincial Integrated Pharmacy Supply Chain Model CIVIC BALLROOM SOUTH Moira Wilson, BSc(Pharm) Horizon Health Network Saint John, NB Hosted by McKesson Canada Corporation Tuesday, February 3 Mardi 3 février 07:30-7:00 Registration Inscription CONCOURSE COAT CHECK 6 Strong Rehabilitation Centre Interior Health Authority: 00 Mile District General Hospital,

17 08:00-08:5 Announcements Annonces DOMINION BALLROOM 08:5-09:5 Use of Social Media in Health Care DOMINION BALLROOM Dr. Mike Evans St. Michael s Hospital Sponsored by Sandoz Canada Inc. 09:30-0:00 Break, Posters, Exhibits Pause, Affiches, Kiosques SHERATON/OSGOODE HALLS 0:5-:00 Concurrent Sessions Séances concomitantes. Recent Trials in Cardiology that Should Impact Your Practice DOMINION BALLROOM Margaret Ackman, BSc(Pharm), PharmD, FCSHP Alberta Health Services Edmonton, AB. Technology in Clinical Practice... Is the Digital Revolution Creating Better Patient Care? BIRCHWOOD BALLROOM Sean Spina, BSc(Pharm), ACPR, PharmD Vancouver Island Health Authority Victoria, BC 3. CSHP 05: Winning Project of the Hospital Pharmacy Residency Award and Winning Success Stories of the National Competition CHESTNUT Facilitator: Carolyn Bornstein, BScPhm, ACPR, FCSHP, CGP Southlake Regional Health Centre Newmarket, ON Award Winning Project: Assessment of the Effect of Behavioural Change Strategies on Knowledge Translation and Pharmacist Interventions for Antimicrobial Stewardship: PIAS-KT Study Sukhjinder Sidhu, BScPhm Medical Pharmacy Calgary, AB :5-:00 Concurrent Sessions Séances concomitantes. Electronic Cigarettes: Seeing Past the Smokescreen PINE Maria Zhang, RPh, BScPhm, PharmD Centre for Addiction and Mental Health. Ebola Virus Disease: Risks, Prevention and Treatment BIRCHWOOD BALLROOM Allison McGeer, MD, FRCPC Mount Sinai Hospital 3. You Can t be a Little Bit Sterile: An Overview of CSHP s Compounding: Guidelines for Pharmacies 04 CHESTNUT Doug Sellinger, BSP, MALT Regina Qu Appelle Health Region Regina, SK :5-3:50 Lunch, Exhibits, Posters Dîner, Kiosques, Affiches SHERATON/OSGOODE HALLS 4:00-5:00 Management of Diabetes in the Acute Illness Setting DOMINION BALLROOM Alice Cheng, MD, FRCPC Trillium Health Partners Mississauga, ON 5:0-7:0 Workshop & PSN Sessions Atelier et séances des RSP. Cardiology PSN RSP en cardiologie DOMINION BALLROOM Drug Induced QT Interval Prolongation in Hospitalized Patients: What s a Pharmacist to Do? James E. Tisdale, PharmD, BCPS, FCCP, FAPhA, FAHA Purdue Univeristy Indianapolis, IN The Impact of Inflammatory Arthritis on Cardiovascular Disease Risk: What It is and What to Do About It! Jill Hall, BScPharm, ACPR, PharmD University of Alberta Edmonton, AB Arrow Lakes Hospital, Ashcroft Hospital and Community Health Care Centre, Boundary 7

18 . Medication Safety PSN RSP en sécurité des médicaments CHESTNUT Reporting Medication Events: You Don t Know What You Don t Know Janice Munroe, BScPharm Fraser Health Services Langley, BC Jennifer Turple, BScPharm, ACPR Institute for Safe Medication Practices Canada Halifax, NS 3. Paediatrics PSN RSP en pédiatrie PINE Controversies in Closure of Patent Ductus Arteriosus Dolores C. Iaboni, BSc(Pharm) Sunnybrook Health Sciences Centre Oral Extemporaneous Compounding References: Pros and Cons Karen Walsh, BScPhm, ACPR, RPh Hospital for Sick Children 4. Workshop Atelier MAPLE To Use or Not to Use the Hospital Pharmacy in Canada Report? Jean-François Bussières, BPharm, MSc, MBA, FCSHP Centre hospitalier universitaire Sainte-Justine Montreal, QC 7:30-9:30 Satellite Symposiums Dinner included Symposiums satellites Souper inclus. Continuity of Care of the ACS Patient CIVIC BALLROOM SOUTH Jennifer Pickering, BScPhm Hamilton Health Sciences Centre Hamilton, ON Claudia Bucci, PharmD Sunnybrook Health Sciences Centre Shaun Goodman, MD St. Michael s Hospital Wednesday, February 4 Mercredi 4 février Hosted by Canadian Cardiovascular Pharmacists Network. Compounding: It s Time to Talk BIRCHWOOD BALLROOM Cathy Lyder, BScPharm, MHSA Canadian Society of Hospital Pharmacists Edmonton, AB Joan Fabbro, BScPharm, ACPR BC Cancer Agency Kelowna, BC Hosted by Hospira Healthcare Corporation 07:30-5:00 Registration Inscription CONCOURSE COAT CHECK 08:00-08:5 Announcements Annonces DOMINION BALLROOM 08:5-09:5 Antimicrobial Resistance: Is it as Scary as Ebola? DOMINION BALLROOM Linda Dresser, PharmD, FCSHP University Health Network 09:5-0:5 HIV Infection and Treatment: A Primer for Pharmacists DOMINION BALLROOM Michelle Foisy, BScPharm, PharmD, ACPR, FCSHP, AAHIVP Northern Alberta HIV Program Edmonton, AB 8 Hospital, Cariboo Memorial Hospital, Creston Valley Hospital & Health Centre, Dr. Helmcken

19 0:5-0:45 Break Pause DOMINION FOYER 0:55-:40 Concurrent Sessions Séances concomitantes. Oncologic Emergencies PINE Sonia Cheung, BScPhm, ACPR, RPh Trillium Health Partners Mississauga, ON. The Limited Role of Aerosolized Antibiotics CHESTNUT Gary Wong, BScPhm University Health Network 3. Practicing Pharmacy with Diverse Populations: Going Beyond Cultural Competency BIRCHWOOD BALLROOM Jeff Wong, BScPharm Hamilton Family Health Team Hamilton, ON :50-:35 Concurrent Sessions Séances concomitantes. Addressing Medication Errors in HIV Inpatients: A Clinician s Guide to Antiretroviral Assessment CHESTNUT Michelle Foisy, BScPharm, PharmD, ACPR, FCSHP, AAHIVP Northern Alberta HIV Program Edmonton, AB 4:5-6:00 PSN Sessions Séances des RSP. Psychiatry PSN RSP en psychiatrie CHESTNUT Mental Health Medication Side Effects in the Workplace Joel Lamoure, RPh, DD, FASCP Western University London, ON Now You Feel Better but Your Heart Doesn t: Cardiovascular Side Effects of Psychotropic Medication Jamie Kellar, RPh, BScHK, BScPhm, PharmD Centre for Addiction and Mental Health. Infectious Diseases PSN RSP en infectiologie BIRCHWOOD BALLROOM Fecal Transplants: What Pharmacists Need to Know Susy Hota, MD, MSc, FRCPC University Health Network What We ve Learned about Antimicrobials from Ontario Databases: Outcomes and Adverse Effects Muhammad Mamdani, PharmD, MA, MPH St. Michael s Hospital 6:5 Close of the 46th Annual Professional Practice Conference Clôture de la 46 e Conférence annuelle sur la pratique professionnelle. Documentation in Electronic Medical Records #FTW PINE Andrew Liu, HBSc, BScPhm, RPh Toronto East General Hospital 3. Are We Choosing Wisely? Quality, Value and Irrationality in Hospital Practice BIRCHWOOD BALLROOM Mark McIntyre, PharmD, ACPR, RPh Mount Sinai Hospital :40-4:0 Lunch Break Please note there is no scheduled satellite symposium. Delegates are on their own for lunch. Memorial Hospital, East Kootenay Regional Hospital, Elk Valley Hospital, Golden & District 9

20 Speaker Abstracts Résumés des conférenciers 0 SUNDAY, FEBRUARY DIMANCHE ER FÉVRIER Clinical Renal Drug Dosing: Is Cockcroft-Gault Dead? Marisa Battistella, BScPhm, PharmD, University of Toronto, Patients with acute or chronic kidney disease require drug dosage adjustment. The challenge, however, is how to accurately estimate a patient s kidney function in both acute and chronic kidney disease to determine drug dosing. Clinicians must assess kidney function and consider how the kidney functionassociated changes in the disposition of drugs and their active or toxic metabolites will impact the drug therapy needs of individual patients. There are numerous ways to calculate the kidney function, each with their own limitations. In this 45 minute session, using patient cases, we will review the different methods to determine renal function and their applicability to drug dosing.. Describe the origins and limitations of serum creatinine and resulting equations used to estimate renal function.. Determine a suitable dosing regimen for a given drug and patient. 3. Using case-based learning, apply dosing principles in a group setting. Self-Assessment Questions. What is the best equation for estimating renal function when drug dosing?. What are key factors to consider when determining drug dosing in a patient with decreased renal function? Drug Induced Sexual Dysfunction Luis Viana, BScPhm., MEd, PharmD, ACPR, CGP, University of Waterloo, Waterloo, ON Human sexual response consists of three phases: libido, sexual arousal and orgasm. Key neurotransmitters involved in human sexual response include dopamine, acetylcholine, serotonin and norepinephrine. Estrogen, testosterone, prolactin, nitric oxide and sex hormone binding globulin also play a role in the human sexual function. In both men and women, impaired sexual response can present as decreased libido. For men, sexual dysfunction can manifest as erectile dysfunction and impairment or absence of ejaculation. For women, diminished vaginal lubrication and decreased genital sensation/swelling can impair the sexual response. Impairment of sexual function as an adverse effect of medications is often under-recognized. An understanding of how medications affect neurotransmitter or hormone levels is important to understanding how medications can impair sexual function. Cardiovascular medications like beta blockers (norepinephrine inhibition), thiazide diuretics (central alpha receptor blockade, decreased dopamine response) and spironolactone (blocks androgen receptors) affect sexual function. Medications with anticholinergic effects affect sexual function by reduction of acetylcholine. Antidepressants like SSRIs, SNRIs and TCA s can affect sexual function by affecting serotonin, acetylcholine, dopamine and prolactin levels. Oral contraceptives and some anticonvulsants can increase sex hormone binding globulin thus reducing free estrogen or testosterone. Drugs that specifically have an anti-hormonal effect, like cancer chemotherapy agents and 5-dihydroxytestorone antagonists, reduce the effects of estrogen or testosterone and can be a cause of sexual dysfunction. Antipsychotic agents cause sexual impairment via anticholinergic effects, decreased dopamine effects and increased prolactin levels. Pharmacists are often the first health care professional sought when a person presents with symptoms of sexual dysfunction that affects their quality of life. It is vital to perform a drug regimen review to identify potential drug induced sexual dysfunction. In some cases, withdrawal of the causative agent or dose reduction is possible. When this is not possible, changing to an alternative medication which is not associated or has less effect on sexual function is an option. Finally, when a causative medication must be continued because of therapeutic benefit, medications which improve sexual function like PDE-5 inhibitors (in men and women) are appropriate if there are no contraindications. Vaginal estrogen cream is an option in women in some situations. Sexual dysfunction is sometimes overlooked as an adverse effect of medications. Advising our patients and providing therapeutic interventions to manage drug induced sexual dysfunction is an important role for pharmacists.. Identify neurotransmitters and other endogenous substance which can influence the three stages of human sexual response.. Examine how drug induced alterations of neurotransmitter balance can affect sexual function. 3. Examine the role of nitric oxide and sex hormone binding globulin in human sexual response. 4. Compare similarities and differences of sexual dysfunction in men and women. 5. Recognize different classes of medications which can cause sexual dysfunction. Hospital, Invermere & District Hospital, Kelowna General Hospital, Kootenay Boundary

21 6. Propose alternative medication management strategies to minimize the effects of drug induced sexual dysfunction. Knowledge Translation Research Primer for Pharmacists: A Practical Approach Monika Kastner, PhD, Li Ka Shing Knowledge Centre, St. Michael s Hospital, Knowledge translation (KT) is a relatively new term to describe an old problem. It is about closing the gap between what we know and what we do, moving research into action, and making users aware of knowledge toward improved health and health care systems. The practice of KT involves developing and implementing a plan for making knowledge users aware of the knowledge generated through a research project. The science of KT is studying the determinants of knowledge use and effective methods of promoting the uptake of knowledge. There are two broad types of KT: ) End-of-grant KT involves the researcher developing and implementing a plan for making knowledge users aware of the knowledge generated through a research project; ) Integrated KT is a way of doing research that engages potential knowledge users as partners in the research process, making it more likely that findings are more relevant and will be used by them. Failure to use research evidence to inform practice ad policy is evidenced across all settings and decision-making groups. To address these challenges, a framework has been developed by Graham and colleagues to help achieve effective knowledge translation called the Knowledge-to-action (KTA) framework. The first concept of the KTA framework is knowledge creation, which conveys the idea that knowledge can be distilled before it is ready to be applied. The second concept of the KTA framework in the action cycle, which emphasizes the dynamic action steps that are needed to apply the knowledge created, and intended to deliberately cause change within health care systems and groups.. To understand the concept of knowledge translation (KT).. To understand the two broad types of KT. 3. To introduce a framework for KT: the knowledge-to-action (KTA) cycle. 4. To illustrate how the KTA framework can be applied in research for translating best evidence into practice. Self-Assessment Questions. Did you find this presentation clear and understandable?. Did the presentation achieve its intended objectives? 3. Was the topic relevant to you? The Hospital Pharmacist: Back to the Future Bill Wilson,RPh, BSP, FCSHP, Mount Sinai Hospital, This presentation will provide the learner with a brief history of Hospital Pharmacy practice and in particular the changing role of the Pharmacist with the purpose of providing context for the future role of Hospital based pharmacists. It is important to understand where the profession has come from and where it is likely to be heading in an effort to optimize the efforts to enhance patient care. The presentation will also provide an update on the current climate in Health care including government funding and changes to reporting requirements that affect hospital Pharmacy. In addition the presentation will discuss the changing demographics and the expectations of the public with respect to their health and health care. The discussion will then attempt to predict or foresee the opportunities for hospital pharmacists in the future and in particular their role both inside and outside the walls of the hospital.. To describe the history of Hospital Pharmacy and to understand the changes in practice that have occurred.. To describe the changing environment public expectations and its impact on practice. 3. To attempt to predict the future roles of Hospital Pharmacists and to describe some strategies on how to get there. PHARMACY SPECIALTY NETWORKSPSN NETW ORK COMMUNICATE Guidance on Guidelines: Applying the New Hypertension and Diabetes Guidelines to the Oldest Old Cheryl Sadowski, BSc(Pharm), PharmD, FCSHP, University of Alberta, Edmonton, AB Multimorbidity is a common presentation in older adults, where multiple disease states and syndromes create challenging cases with conflicting choices. This is most common in the oldest old, defined as seniors age 80 years and older. This population lives with many comorbidities, but they are often excluded from clinical trials, and many guidelines do not provide direction specific to this age group. Most clinical practice guidelines are based on a single disease, and recommendations are built on evidence that comes from clinical trials that enroll a narrow patient population without multimorbidity. This results in poor applicability to the patient population, as recommendations for one guideline can directly contradict the recommendation from another guideline that would be relevant for the same patient. This conundrum applies to commonly used guidelines, such as diabetes or hypertension. While some comorbidities are discussed within each guideline, the multimorbidity patient is not used as an example, and pharmacists are still left with many challenges of how to apply the evidence-based recommendations to a complex geriatric patient. To provide direction to clinicians, the American Geriatrics Society (AGS) developed guidelines for guidelines, direction on how to address decision making and care for patients with multimorbidity. This presentation will focus on application of the AGS principles of care in relation to the most current hypertension and diabetes guidelines. Regional Hospital, Kootenay Lake Hospital, Lillooet Hospital & Health Centre, Nicola Valley

22 After attending this session the participant should be able to:. Describe the challenges of applying current evidence to an older adult population.. Identify the guideline recommendations that apply to older adults. 3. Contrast the health care needs of the fit versus frail older adult. 4. Apply guideline recommendations in a context of complexity, comorbidity, and frailty. Self-Assessment Questions. Based on the AGS Principles of Care, what is the first step in making a decision about therapy for an older adult?. Identify 3 ways the hypertension and diabetes guidelines can be improved to address care for older adults age 80 years and older. PHARMACY SPECIALTY NETWORKSPSN NETW ORK COMMUNICATE Medication-Related Emergency Room Admissions in the Elderly Saurabh Patel, BScPharm, Orillia Soldiers Memorial Hospital, Orillia, ON In Canada, approximately, 65% of people older than 65 take more than 5 medications daily with 5% of this population taking more than 0 medications. In the next four decades, the elderly population will double and seniors will be living an average of 5 years longer, leading to a significant increase in healthcare utilization including consumption of multiple medications. The elderly are at increased risk of drug-drug interactions and adverse drug events with use of multiple medications to treat acute and chronic conditions. It is estimated that 0% of the emergency department admissions can be attributed to medications. Pharmacists are in key position to identify, treat, and prevent these drug-drug interactions and adverse drug events. This presentation will outline common medication culprits and drugdrug interactions that are a common cause for admission to the emergency department. The presentation will also highlight how polypharmacy and prescribing cascades may contribute to hospitalization in the elderly population. Finally, the presentation will outline strategies pharmacists can use to optimize medication regimens in the elderly. Goals and objectives of the presentation will be covered with real cases and evidence from the literature.. Outline the epidemiology of the aging population and their use of medications.. Discuss pharmacokinetic and pharmacodynamic changes associated with aging and the implication for use of medications in older adults. 3. Identify medications or classes of medications that put older adults at risk of hospitalization (i.e. ER admissions). 4. Review drug-drug interactions that are clinically relevant in older adults. 5. Review polypharmacy and prescribing cascades that may increase risk of hospitalization in older adults. Self-Assessment Questions. List medications or classes of medications that have shown to increase risk of hospitalization in older adults.. Outline strategies to optimize medication regimens in older adults to prevent unnecessary hospitalizations. PHARMACY SPECIALTY NETWORKSPSN NETW ORK COMMUNICATE Overview of Inhalers for Chronic Obstructive Pulmonary Disease: Hospital Formulary Considerations Lawrence Jackson, BScPhm, Sunnybrook Health Sciences Centre, ; Rosa Maria Tanzini, BScPhm, St. Michael s Hospital, An onslaught of new inhalation therapies and new inhaler devices mainly targeting the COPD population, have recently been marketed or are anticipated. This session addresses formulary management issues and provides an approach to analyzing hospital formulary requirements, taking into account the context of when the inhaler is being initiated and used, device selection and discharge planning. Managing Chronic Obstructive Pulmonary Disease (COPD) imposes a high burden and cost impact on the healthcare system. As such, preventing acute exacerbations of COPD has become a focus of many studies. A partnership between American College of Chest Physicians and Canadian Thoracic Society has produced preliminary guidelines on prevention of acute exacerbations. New inhaled medications include long-acting anticholinergics/ muscarinic receptor antagonists (LAMA), ultra long-acting beta- agonists (LABA), inhaled corticosteroid/ultra long-acting beta- agonist combinations (ICS/LABA) and long-acting muscarinic antagonist/long-acting beta-agonist combinations (LAMA/ LABA). Range of products and devices provides options which may make treatment more convenient (in particular, combination products) and permit strategies to improve efficacy/tolerance. This session will highlight some of the differences between the therapeutic alternatives and devices, as well as discuss factors which may influence formulary decisions.. Introduce the new inhalers and identify potential place in therapy.. Highlight recently published COPD guidelines. 3. Address hospital formulary requirements. Hospital and Health Centre, Penticton Regional Hospital, Princeton General Hospital, Queen